Expert consensus on comprehensive clinical evaluation of antidepressant drugs
- VernacularTitle:抗抑郁药品临床综合评价专家共识
- Author:
Tianmei SI
1
;
Zhen WANG
2
;
Lingjiang LI
3
Author Information
1. Peking University Sixth Hospital/National Clinical Research Center for Psychiatric and Mental Disorders，Beijing 100191，China
2. Shanghai Mental Health Center Affiliated to Shanghai Jiao Tong University School of Medicine/National Center for Mental Disorder，Shanghai 200030，China
3. Psychic Health Research Institute，the Second Xiangya Hospital of Central South University，Changsha 410011，China
- Publication Type:Journal Article
- Keywords:
antidepressant drugs;
comprehensive clinical evaluation;
expert consensus;
rational drug use
- From:
China Pharmacy
2023;34(13):1547-1554
- CountryChina
- Language:Chinese
-
Abstract:
At present， many antidepressant drug categories have been marketed in China， but still lack a scientific and standardized system for drug comprehensive clinical evaluation. To guide and promote medical institutions to standardize the comprehensive clinical evaluation of antidepressant drugs， 19 clinical， pharmacy and evidence-based medicine experts from China were organized by the China Population Welfare Foundation to evaluate 11 drugs in 5 categories， including sertraline/escitalopram/ paroxetine/fluvoxamine/citalopram/fluoxetine/venlafaxine/duloxetine/vortioxetine/agomelatine/mirtazapine， through seminars and interviews， concerning clinical real-world data and evidence-based medicine， and to form the first draft of Expert Consensus on Comprehensive Clinical Evaluation of Antidepressant drugs， which is finalized after peer review by 18 clinical and pharmacy experts. The evaluation system of this expert consensus adopts the quantitative evaluation system of percentile and carries out a systematic evaluation from 6 dimensions of effectiveness， safety， economy， suitability， accessibility and innovativeness， while the evaluation dimensions are more detailed， with the operability of the drug evaluation system and the characteristics of drugs in the field of antidepressants. It aims to provide a theoretical basis for the rational use of drugs in the field of psychiatric disorders in medical institutions and help improve the quality of pharmacy services to better meet the needs of the people for medication.
